Biotech

All Articles

Bicara, Zenas look for IPOs to drive late-phase properties toward market

.Bicara Rehabs and Zenas Biopharma have actually provided clean incentive to the IPO market along wi...

Genentech to close cancer immunology research division

.Genentech will shut its own cancer immunology analysis division, and also device mind and popular c...

Kezar drops strong lump however to prove its truly worth in stage 1 trial

.Kezar Lifestyle Sciences is actually dropping its unpromising phase 1 solid cyst drug as the biotec...

Acelyrin drops izokibep, lets go 3rd of team

.Regardless of izokibep keeping its newly found winning touch in the facility, Acelyrin is no more c...

Rivus' phase 2 obesity-related cardiac arrest test hits endpoint

.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...

Ovid stops preclinical work, IV plan after soticlestat fail

.Ovid Therapeutics presently disclosed final month that it was actually trimming its own head count ...

Eli Lilly opens up $700M nucleic acid R&ampD facility in Boston ma Port

.Eli Lilly has actually opened a $700 thousand R&ampD facility in the Boston Port, improving its own...

Boundless Bio produces 'modest' unemployments five months after $100M IPO

.Only five months after safeguarding a $100 million IPO, Limitless Biography is actually laying off ...

Halda's $126M will definitely accelerate 'hold and also get rid of' cyst medicines

.The initial phases of oncology R&ampD may not be except fascinating brand new methods, as well as H...

Lykos 'remorses' certainly not disclosing research offenses with publisher

.Psychopharmacology has drawn 3 articles about midstage clinical trial information determining Lykos...